Pfizer Inc (PFE) insider trading
Every open-market stock purchase and sale by Pfizer Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Albert Bourla (CEO) and 2 others bought $3M in the last 90 days, growing their stake 10%.
- Jennifer B. Damico (VP) sold $83.3K in the last 90 days.
- Congress: Thomas H Tuberville sold $15K to $50K, 5 months ago.
Last 12 months: insiders bought $3M (3 buys) and sold $135K (2 sales). Last close $29.85 on Oct 21, 2026.
Recent PFE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Albert Bourla (CEO) | Bought (not open market) | $589 |
| Oct 13, 2026 | Albert Bourla (CEO) | Bought (not open market) | $2K |
| Sep 30, 2026 | Albert Bourla (CEO) | Bought (not open market) | $599 |
| Sep 25, 2026 | Shantanu Narayen (Director) | Bought (not open market) | $50K |
| Sep 25, 2026 | Joseph Echevarria (Director) | Bought (not open market) | $46.3K |
| Sep 25, 2026 | James C Smith (Director) | Bought (not open market) | $45K |
| Sep 25, 2026 | James Quincey (Director) | Bought (not open market) | $38.8K |
| Sep 25, 2026 | Cyrus Taraporevala (Director) | Bought (not open market) | $37.5K |
| Sep 25, 2026 | Mortimer J Buckley (Director) | Bought (not open market) | $37.5K |
| Sep 15, 2026 | Albert Bourla (CEO) | Bought (not open market) | $606 |
| Aug 31, 2026 | Albert Bourla (CEO) | Bought (not open market) | $598 |
| Aug 14, 2026 | Albert Bourla (CEO) | Bought (not open market) | $589 |
| Aug 12, 2026 | Albert Bourla (CEO) | Bought | $1M |
| Aug 5, 2026 | Ronald E Blaylock (Director) | Bought | $999K |
| Aug 5, 2026 | Mortimer J Buckley (Director) | Bought | $960K |
| Aug 5, 2026 | Jennifer B. Damico (VP) | Sold | $83.3K |
| Jul 31, 2026 | Albert Bourla (CEO) | Bought (not open market) | $600 |
| Jul 15, 2026 | Albert Bourla (CEO) | Bought (not open market) | $596 |
| Jul 9, 2026 | Albert Bourla (CEO) | Bought (not open market) | $2K |
| Jun 30, 2026 | Albert Bourla (CEO) | Bought (not open market) | $602 |
| Jun 26, 2026 | Shantanu Narayen (Director) | Bought (not open market) | $50K |
| Jun 26, 2026 | Joseph Echevarria (Director) | Bought (not open market) | $46.3K |
| Jun 26, 2026 | James C Smith (Director) | Bought (not open market) | $45K |
| Jun 26, 2026 | James Quincey (Director) | Bought (not open market) | $38.8K |
| Jun 26, 2026 | Cyrus Taraporevala (Director) | Bought (not open market) | $37.5K |
Who's trading PFE
- Albert Bourla, CEO: bought $1M (1 buy), last Oct 15, 2026
- Joseph Echevarria, Director: other filings, last Sep 25, 2026
- Shantanu Narayen, Director: other filings, last Sep 25, 2026
- Cyrus Taraporevala, Director: other filings, last Sep 25, 2026
- James C Smith, Director: other filings, last Sep 25, 2026
- Mortimer J Buckley, Director: bought $960K (1 buy), last Sep 25, 2026
- James Quincey, Director: other filings, last Sep 25, 2026
- Ronald E Blaylock, Director: bought $999K (1 buy), last Aug 5, 2026
- Jennifer B. Damico, VP: sold $135K (2 sales), last Aug 5, 2026
- Thomas H Tuberville, Senator: sold $32.5K (1 sale), last Jun 8, 2026
- Scott Gottlieb, Director: other filings, last Apr 23, 2026
- Dan R. Littman, Director: other filings, last Apr 23, 2026
- Susan Desmond-Hellmann, Director: other filings, last Apr 23, 2026
- Johnson Suzanne M Nora, Director: other filings, last Apr 23, 2026
- Alan Armstrong, Senator: sold $75K (1 sale), last Mar 24, 2026
Get free alerts when an insider at Pfizer Inc files a new trade →